Fibrinolytic activity and haemagglutination inhibition immunoassays.
D000328:Adult; D000368:Aged; D001645:Biguanides / Q000494:pharmacology; D002994:Clofibrate / Q000494:pharmacology; D003327:Coronary Disease / Q000097:blood; D005032:Ethylestrenol / Q000494:pharmacology; D005260:Female; D005337:Fibrin / Q000032:analysis*; D005340:Fibrinogen / Q000032:analysis*; D005342:Fibrinolysis / Q000187:drug effects; D006385:Hemagglutination Inhibition Tests; D006487:Hemostasis; D006801:Humans; D007118:Immunoassay; D005779:Immunodiffusion; D007122:Immunoelectrophoresis; D008103:Liver Cirrhosis / Q000097:blood; D008297:Male; D008687:Metformin / Q000494:pharmacology; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009539:Nicotinic Acids / Q000494:pharmacology; D005082:Physical Exertion; D010958:Plasminogen / Q000032:analysis; D011471:Prostatic Neoplasms / Q000097:blood; D013268:Stimulation, Chemical; D013997:Time Factors; D014042:Tolazamide / Q000494:pharmacology
D001645:Biguanides; D009539:Nicotinic Acids; D005337:Fibrin; D005340:Fibrinogen; D010958:Plasminogen; D008687:Metformin; D014042:Tolazamide; D005032:Ethylestrenol; D002994:Clofibrate